Please Wait

Applying Filters...

Drug Product Composition: Mycoster

Mycoster

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 6 USDMF, 5 CEP/COS, 1 KDMF, 5 NDC API, 6 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

94 FDF Dossiers, 32 FDA Orange Book, 53 Europe, 5 Canada, 1 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.77%, SUSPENSION;TOPICAL - 0.77%, GEL;TOPICAL - 0.77% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;TOPICAL - 8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SHAMPOO;TOPICAL - 1%

RELATED EXCIPIENT COMPANIES

1 Seqens, 1 DKSH, 5 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 2 Actylis, 8 BASF, 2 Corel Pharma Chem, 1 Finar, 2 Lubrizol Life Science Health, 1 Pluviaendo, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Topical, 7 Parenteral, 5 Solubilizers, 3 Thickeners and Stabilizers, 3 Film Formers & Plasticizers, 3 Granulation, 2 Emulsifying Agents, 2 Lubricants & Glidants, 2 Taste Masking, 2 Coating Systems & Additives, 1 Controlled & Modified Release, 1 Direct Compression, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 38 Regulatory FDF Prices

MARKET PLACE

9 APIs

9 APIs

REF. STANDARDS & IMPURITIES

4 EDQM, 10 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21159 / DOSAGE - SHAMPOO;TOPICAL - 1%

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ciclopirox(UNII: 19W019ZDRJ) (ciclopirox - UNII:19W019ZDRJ)	ciclopirox	10mg in 0.96

Inactive Ingredients

Ingredient Name	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	Fougera Pharmaceuticals Inc.	Padagis Israel Pharmaceuticals Ltd
DISODIUM LAURETH SULFOSUCCINATE(D6DH1DTN7E)
LAURETH-2(D4D38LT1L5)
SODIUM CHLORIDE(451W47IQ8X)
sodium laureth-3 sulfate(BPV390UAP0)
WATER(059QF0KO0R)

Drug Product Composition: Mycoster

Mycoster

Mycoster

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers

6 USDMF

5 CEP/COS

1 KDMF

5 NDC API

6 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

94 FDF Dossiers

32 FDA Orange Book

53 Europe

5 Canada

1 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.77%

SUSPENSION;TOPICAL - 0.77%

GEL;TOPICAL - 0.77% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;TOPICAL - 8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SHAMPOO;TOPICAL - 1%

RELATED EXCIPIENT COMPANIES

1 Seqens

1 DKSH

5 Nanjing Well Pharmaceutical

1 Kirsch Pharma

2 Actylis

8 BASF

2 Corel Pharma Chem

1 Finar

2 Lubrizol Life Science Health

1 Pluviaendo

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Topical

7 Parenteral

5 Solubilizers

3 Thickeners and Stabilizers

3 Film Formers & Plasticizers

3 Granulation

2 Emulsifying Agents

2 Lubricants & Glidants

2 Taste Masking

2 Coating Systems & Additives

1 Controlled & Modified Release

1 Direct Compression

1 Surfactant & Foaming Agents

DIGITAL CONTENT

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions

38 Regulatory FDF Prices

MARKET PLACE

9 APIs

REF. STANDARDS & IMPURITIES

4 EDQM

10 Others

Filters

GEL;TOPICAL - 0.77% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;TOPICAL - 8% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons